JVMRX
Price
$25.43
Change
-$1.50 (-5.57%)
Updated
Apr 3 closing price
Net Assets
21.35B
NQVAX
Price
$51.84
Change
-$3.03 (-5.52%)
Updated
Apr 3 closing price
Net Assets
463.46M
Ad is loading...

JVMRX vs NQVAX

Header iconJVMRX vs NQVAX Comparison
Open Charts JVMRX vs NQVAXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$25.43
Change-$1.50 (-5.57%)
VolumeN/A
Net Assets21.35B
Nuveen Multi Cap Value A
Price$51.84
Change-$3.03 (-5.52%)
VolumeN/A
Net Assets463.46M
JVMRX vs NQVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMRX vs. NQVAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Hold and NQVAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 21.4B vs. NQVAX (463M). NQVAX pays higher dividends than JVMRX: NQVAX (1.30) vs JVMRX (0.94). JVMRX was incepted earlier than NQVAX: JVMRX (14 years) vs NQVAX (22 years). NQVAX (1.17) is less costly to investors than JVMRX (0.76). JVMRX is a more actively managed with annual turnover of: 47.00 vs. NQVAX (24.00). NQVAX has a lower initial minimum investment than JVMRX: NQVAX (2500) vs JVMRX (1000000). NQVAX annual gain was more profitable for investors over the last year : 11.54 vs. JVMRX (-7.83). NQVAX return over 5 years is better than : 172.85 vs. JVMRX (90.92).
JVMRXNQVAXJVMRX / NQVAX
Total Expense Ratio0.751.1665%
Annual Report Gross Expense Ratio0.761.1765%
Fund Existence14 years22 years-
Gain YTD-0.0370.771-5%
Front LoadN/A6%-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.4B463M4,622%
Annual Yield % from dividends0.941.3072%
Returns for 1 year-7.8311.54-68%
Returns for 3 years-0.3230.02-1%
Returns for 5 years90.92172.8553%
Returns for 10 years34.80131.9526%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PXWEX31.64N/A
N/A
Impax Ellevate Global Women's Ldr Inv
FASMX20.60N/A
N/A
Fidelity Asset Manager 50%
NEAMX31.34N/A
N/A
Neiman Large Cap Value A
PCSMX13.52N/A
N/A
Principal SmallCap Growth I R6
WFEHX13.61N/A
N/A
Allspring International Equity R6